V & R Test

The V & R Benzodiazepine Drug Test offers a high-performance, presumptive screening solution for identifying Valium® (Diazepam) and Rohypnol® (Flunitrazepam).

Because early detection is critical in forensic and clinical settings, this test delivers fast, dependable results within minutes. Professionals use this tool to make timely decisions during initial evaluations without waiting for complex laboratory analysis.

This screening tool uses reliable immunoassay-based technology to detect benzodiazepine-related compounds at established cutoff levels. Consequently, potential exposure or misuse can be identified efficiently and with high confidence. The test remains highly sensitive to low concentrations of Diazepam and Flunitrazepam, making it an essential asset for identifying drug-facilitated incidents or sedation-related impairment.

The V & R test is designed for maximum usability in diverse environments. For instance, the procedure requires no specialised training or expensive laboratory equipment. To begin, a user simply applies the sample to the test unit and waits for the clear visual indicators to appear. Because of this easy-to-read format, personnel in workplaces, clinics, and rehabilitation centres can interpret outcomes accurately every time.

While this kit serves as a first-line screening solution, it remains a presumptive tool. Therefore, a positive result should always be followed by confirmatory laboratory methods such as GC/MS or LC/MS. This process ensures compliance with professional regulatory standards while maintaining a practical workflow for high-volume screening programmes.